Murakami T - Search Results

1

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.

Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T. Kudo M, et al. Among authors: murakami t. Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19. Liver Cancer. 2021. PMID: 34239808 Free PMC article. Review.

2

Hypervascular hepatocellular carcinoma: Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP.

Imai Y, Murakami T, Hori M, Fukuda K, Kim T, Marukawa T, Abe H, Kuwabara M, Onishi H, Tsuda K, Sawai Y, Kurokawa M, Hayashi N, Monden M, Nakamura H. Imai Y, et al. Among authors: murakami t. Hepatol Res. 2008;38(2):147-58. doi: 10.1111/j.1872-034X.2007.00210.x. Epub 2007 Jul 20. Hepatol Res. 2008. PMID: 17645518

3

Safety of ferucarbotran in MR imaging of the liver: a pre- and postexamination questionnaire-based multicenter investigation.

Onishi H, Murakami T, Kim T, Hori M, Hirohashi S, Matsuki M, Narumi Y, Imai Y, Sakurai K, Nakamura H. Onishi H, et al. Among authors: murakami t. J Magn Reson Imaging. 2009 Jan;29(1):106-11. doi: 10.1002/jmri.21608. J Magn Reson Imaging. 2009. PMID: 19097079

4

Consensus report of the 2nd International Forum for Liver MRI.

Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L. Tanimoto A, et al. Among authors: murakami t. Eur Radiol. 2009 Oct;19 Suppl 5:S975-89. doi: 10.1007/s00330-009-1624-y. Eur Radiol. 2009. PMID: 19851766

5

Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging.

Okada M, Imai Y, Kim T, Kogita S, Takamura M, Kumano S, Onishi H, Hori M, Fukuda K, Hayashi N, Wakasa K, Sakamoto M, Murakami T. Okada M, et al. Among authors: murakami t. J Magn Reson Imaging. 2010 Oct;32(4):903-13. doi: 10.1002/jmri.22333. J Magn Reson Imaging. 2010. PMID: 20882621

6

Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.

Kagawa Y, Okada M, Kumano S, Katsube T, Imaoka I, Tanigawa N, Ishii K, Kudo M, Murakami T. Kagawa Y, et al. Among authors: murakami t. J Magn Reson Imaging. 2011 Apr;33(4):864-72. doi: 10.1002/jmri.22487. J Magn Reson Imaging. 2011. PMID: 21448951

7

[Advances in imaging modalities of hepatocellular carcinoma].

Imai Y, Kogita S, Igura T, Sawai Y, Ohama H, Fukuda K, Seki Y, Takamura M, Okada M, Murakami T. Imai Y, et al. Among authors: murakami t. Nihon Shokakibyo Gakkai Zasshi. 2011 Jun;108(6):916-27. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 21646759 Japanese. No abstract available.

8

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M; HCC Expert Panel of Japan Society of Hepatology. Kudo M, et al. Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9. Dig Dis. 2011. PMID: 21829027

9

Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.

Alaboudy A, Inoue T, Hatanaka K, Chung H, Hyodo T, Kumano S, Murakami T, Moustafa EF, Kudo M. Alaboudy A, et al. Among authors: murakami t. Oncology. 2011;81 Suppl 1:66-72. doi: 10.1159/000333264. Epub 2011 Dec 22. Oncology. 2011. PMID: 22212939

10

Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.

Murakami T, Imai Y, Okada M, Hyodo T, Lee WJ, Kim MJ, Kim T, Choi BI. Murakami T, et al. Oncology. 2011;81 Suppl 1:86-99. doi: 10.1159/000333267. Epub 2011 Dec 22. Oncology. 2011. PMID: 22212941 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,503 results

Search Page